SGL5213, a novel and potent intestinal SGLT1 inhibitor, suppresses intestinal glucose absorption and enhances plasma GLP-1 and GLP-2 secretion in rats
収録刊行物
-
- European Journal of Pharmacology
-
European Journal of Pharmacology 853 136-144, 2019-06
Elsevier BV